Research reports Here you can directly download the research reports of nuclear medicine of the past years: Nuclear Medicine Research Reports OE8250-Clinical Department of Nuclear Medicine 2011.pdf Nu

Download area Information brochure Technology Partnership Information brochure Technology Partnership Patient flyer for modern cardiac SPECT Patient flyer for modern cardiac SPECT Patient flyer genera

Radiopharmaceutical chemistry Welcome to the homepage of the Radiopharmaceutical Chemistry Department of the Clinical Department of Nuclear Medicine at Hannover Medical School. On the following pages

At the MHH, pioneering work was done to establish peptide receptor radionuclide therapy (PRRT). This is a new, highly effective procedure for the targeted treatment of neuroendocrine tumors. The docum

Checklist for registration for patients and referring physicians can be found here . For further information you can download the Brochure for radioiodine therapy download. At our nuclear medicine the

PSMA PET-CT before therapy (left) and post-therapy scan after administration of Lu-177 PSMA for metastasis treatment (right). Distribution of the therapeutic agent as predicted by PET-CT The latest fo

Thyroid outpatient clinic Patients with benign and malignant thyroid diseases are treated here. The focus is on on the direct pre- and direct post-inpatient care of patients with indications for radio

Targeted therapy with open radioactive substances is highly effective and a central component of the field of nuclear medicine. After a conversion phase of over 2 years, operations at the radionuclide

For specific nuclear medicine questions about selective internal radiotherapy (SIRT) Dr. Brunkhorst Tel 0511 / 532 - 4023 Inpatient appointments for radioiodine diagnostics/therapy for benign and mali

The Radionuclide Therapy Ward (Ward 75) of the Clinical Department of Nuclear Medicine at MHH is a special ward with 10 beds for targeted molecular treatment with open radioactive substances. Followin